MedPath

Effects of L-Carnitine on Gastric Emptying in Children With Drug Resistant Epilepsy on Ketogenic Diet

Not Applicable
Completed
Conditions
Ketogenic Diet
Interventions
Dietary Supplement: L- Carnitine
Other: ketogenic diet
Registration Number
NCT06255873
Lead Sponsor
Ain Shams University
Brief Summary

This study was conducted on thirty children aged from12 months to 18 years newly diagnosed with drug resistant epilepsy and following up at Pediatric Nutrition and Neurology Outpatient Clinics assigned randomly into 2 groups, group1: patients who started ketogenic diet with L-carnitine and group2: patients who started ketogenic diet only.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • All infants and children aged from 12 months to 18 years old newly diagnosed with drug resistant epilepsy and were assigned to start KD.
Exclusion Criteria
  • Patients with intolerance or non-compliance to ketogenic diet therapy.
  • Patients for epilepsy surgery or vagal nerve stimulation.
  • Children with history of previous abdominal operations.
  • Children with history of GI diseases affecting GI motility before starting KD.
  • Children with tube feeding or feeding gastrostomy or jejunostomy.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ketogenic diet with L - Carnitine supplementation.L- CarnitinePatients with drug resistant epilepsy who received ketogenic diet with L - Carnitine supplementation.
ketogenic diet.ketogenic dietPatients with drug resistant epilepsy who received ketogenic diet only.
ketogenic diet with L - Carnitine supplementation.ketogenic dietPatients with drug resistant epilepsy who received ketogenic diet with L - Carnitine supplementation.
Primary Outcome Measures
NameTimeMethod
Assessment the effect of L-carnitine supplementation on gastric emptying in children with drug resistant epilepsy (DRE) on ketogenic diet (KD).At time of enrollment and 3 months of intervention.

Antral length measurement using abdominal ultrasonography.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Faculty of Medicine-Ain Shams University

🇪🇬

Cairo, Abbasia, Egypt

© Copyright 2025. All Rights Reserved by MedPath